Next Article in Journal
Response to “Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment”
Previous Article in Journal
Systemic Treatment Safety Symposium 2014: Oral Chemotherapy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 21
Issue 6
10.3747/co.21.2177
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment

by
Lucia A. Villemagne–Sanchez
1,*,
David M. Ross
2,3,4 and
Penelope Schofield
5
1
Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia
2
Hematology Directorate, SA Pathology School of Medicine, University of Adelaide
3
Flinders University, Adelaide, Australia
4
Medical Centre, Adelaide, Australia
5
Faculty of Medicine, Dentistry and Health Sciences, Sir Peter MacCallum Department of Oncology, Australia Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, The University of Melbourne, Locked Bag 1, A’Beckett Street, Victoria 8006, Australia
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(6), 801-802; https://doi.org/10.3747/co.21.2177
Submission received: 3 September 2014 / Revised: 4 October 2014 / Accepted: 11 November 2014 / Published: 1 December 2014

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Sanford et al. reported results from an interviewassisted survey of chronic myeloid leukemia (CML) patients, which indicated that neither treatment compliance nor the occurrence of side effects significantly affected patient willingness to stop tyrosine kinase inhibitor treatment1.[...]

Share and Cite

MDPI and ACS Style

Villemagne–Sanchez, L.A.; Ross, D.M.; Schofield, P. Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment. Curr. Oncol. 2014, 21, 801-802. https://doi.org/10.3747/co.21.2177

AMA Style

Villemagne–Sanchez LA, Ross DM, Schofield P. Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment. Current Oncology. 2014; 21(6):801-802. https://doi.org/10.3747/co.21.2177

Chicago/Turabian Style

Villemagne–Sanchez, Lucia A., David M. Ross, and Penelope Schofield. 2014. "Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment" Current Oncology 21, no. 6: 801-802. https://doi.org/10.3747/co.21.2177

APA Style

Villemagne–Sanchez, L. A., Ross, D. M., & Schofield, P. (2014). Need to Minimize Bias When Surveying Patient Attitudes to Stopping cml Treatment. Current Oncology, 21(6), 801-802. https://doi.org/10.3747/co.21.2177

Article Metrics

Back to TopTop